Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Orion Nutraceuticals Inc C.ORI

Orion Nutraceuticals Inc. is a Canada-based company. The Company is primarily focused on re-purposing a United States food and drug administration approved drug to target asthma and chronic obstructive pulmonary disease (COPD).


CSE:ORI - Post by User

Post by SolidInvestmenton Sep 16, 2019 2:37pm
158 Views
Post# 30132280

Options granted.

Options granted.
Orion grants option to buy 300,000 shares 2019-09-16 14:28 ET - News ReleaseMr. Joel Dumaresq reports ORION NUTRACEUTICALS ANNOUNCES GRANT OF STOCK OPTIONS Orion Nutraceuticals Inc. has granted incentive stock options of the company to Sam Jenkins for the right to purchase up to an aggregate of 300,000 common shares of the company, exercisable at the price of 15 cents per share for two years. The effective date of the grant of option is Sept. 13, 2019. The stock options granted will be in accordance with the company's stock option plan and will have the required four-month hold period legend, pursuant to the policies of the Canadian Securities Exchange and regulatory authorities. About Orion Nutraceuticals Inc. Orion Nutraceuticals aims to set a new standard in cannabis life science by producing and developing innovative products with key strategic partners in the industry. In conjunction with its professional sports strategic alliances, the company is poised to advance research and development in the plant science sector, deliver science-based products and services, and market cannabidiol therapies to the mainstream with proprietary brands and products.
<< Previous
Bullboard Posts
Next >>
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse